← Prenetics Global Ltd
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $65.2m |
$275.9m
+323.22%
|
$275.8m
-0.03%
|
$21.7m
-92.12%
|
$30.6m
+40.83%
|
$92.4m
+201.72%
|
$120.1m
+29.96%
|
|
| Cost of Revenue | $38.8m |
$169.7m
+337.04%
|
$144.2m
-15.03%
|
$12.9m
-91.05%
|
$15.2m
+17.88%
|
$43.6m
+186.45%
|
$53.6m
+22.94%
|
|
| Gross profit | $26.3m |
$106.1m
+302.85%
|
$131.6m
+23.95%
|
$8.8m
-93.29%
|
$15.4m
+74.41%
|
$48.8m
+216.82%
|
$66.5m
+36.23%
|
|
| Research and development expenses | ($2.8m) | ($10.6m) | ($15.5m) | ($11.7m) | ($10.9m) | ($5.1m) | $4.6m | |
| Selling and marketing expenses | — | — | — | ($5.5m) | ($5.4m) | ($35.5m) | $101.6m | |
| Administrative and other operating expenses | ($16.6m) | ($84.0m) | ($96.1m) | ($41.4m) | ($46.7m) | ($46.4m) | — | |
| Operating loss from continuing operations | ($995k) | ($10.2m) | ($23.3m) | ($51.9m) | ($48.1m) | ($44.5m) | — | |
| Other income and other net gains | ($315k) | $139k | $405k | $4.5m | $2.7m | $614k | — | |
| Income tax (expense)/credit | $1.9m | ($3.7m) | ($7.1m) | $269k | $7.9m | ($34k) | $42k | |
| Basic loss per share (USD per share) | ($0.15) | ($11.92) | ($2.50) | ($5.58) | ($3.71) | ($2.68) | — | |
| Diluted loss per share (USD per share) | ($0.15) | ($11.92) | ($2.50) | ($5.58) | ($3.71) | ($2.68) | — | |
| Basic loss per share from continuing operations (USD per share) | — | ($225.17) | ($44.50) | ($4.83) | ($3.71) | ($2.46) | — | |
| Diluted loss per share from continuing operations (USD per share) | — | ($225.17) | ($44.50) | ($4.83) | ($3.71) | ($2.46) | — | |
| Direct costs | ($38.8m) | ($169.7m) | ($144.2m) | ($12.9m) | ($15.2m) | ($43.6m) | — | |
| Impairment of goodwill | — | $0 | $0 | ($3.9m) | $0 | ($6.8m) | — | |
| Fair value gain/(loss) on financial assets at fair value through profit or loss | — | — | ($9.4m) | ($7.1m) | ($8.9m) | $780k | — | |
| Gain on warrant exchange | — | — | — | $0 | $0 | $36.7m | — | |
| Fair value (loss)/gain on warrant liabilities | — | $0 | $3.2m | $3.4m | $49k | ($17.9m) | — | |
| Unrealized fair value loss on digital assets | — | — | — | $0 | $0 | ($9.7m) | — | |
| Gain on partial disposal of an equity-accounted investee | — | — | $0 | $0 | $1.2m | $0 | — | |
| Share of loss of equity-accounted investees, net of tax | ($1.1m) | $0 | $0 | ($859k) | ($1.8m) | ($1.3m) | — | |
| Other finance costs | ($60k) | ($5.2m) | ($4.2m) | ($120k) | ($203k) | ($241k) | — | |
| Loss before taxation | ($3.9m) | ($170.3m) | ($183.3m) | ($56.7m) | ($57.7m) | ($36.2m) | — | |
| Loss from continuing operations | — | ($219.1m) | ($225.6m) | ($56.4m) | ($49.8m) | ($36.2m) | — | |
| Loss from discontinued operations, net of tax | — | $45.1m | $35.1m | ($8.4m) | $22k | ($3.7m) | — | |
| Loss for the year | ($2.0m) | ($174.0m) | ($190.5m) | ($64.8m) | ($49.8m) | ($40.0m) | — | |
| Share of other comprehensive (expense)/income of equity-accounted investees | — | — | $0 | $0 | $303k | ($26k) | — | |
| Exchange differences on translation of foreign operations | $1.6m | $260k | ($4.8m) | $1.8m | ($1.0m) | $716k | — | |
| Reclassification of cumulative translation reserve upon disposal of foreign operations | — | — | — | $0 | $0 | ($74k) | — | |
| Other comprehensive income/(expense) for the year | — | — | ($4.8m) | $1.8m | ($721k) | $616k | — | |
| Equity shareholders of the Company | ($358k) | ($173.7m) | ($195.3m) | ($61.1m) | ($46.8m) | ($37.2m) | — | |
| Non-controlling interests | ($24k) | ($8k) | ($54) | ($1.9m) | ($3.7m) | ($2.2m) | — | |
| Total comprehensive expense for the year | ($383k) | ($173.8m) | ($195.3m) | ($63.0m) | ($50.5m) | ($39.4m) | — |